GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (FRA:LSI) » Definitions » Days Payable

CK Life Sciences International Holdings (FRA:LSI) Days Payable : 49.55 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings Days Payable?

CK Life Sciences International Holdings's average Accounts Payable for the six months ended in Dec. 2023 was €60.8 Mil. CK Life Sciences International Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was €223.8 Mil. Hence, CK Life Sciences International Holdings's Days Payable for the six months ended in Dec. 2023 was 49.55.

The historical rank and industry rank for CK Life Sciences International Holdings's Days Payable or its related term are showing as below:

FRA:LSI' s Days Payable Range Over the Past 10 Years
Min: 28.69   Med: 39.05   Max: 106.67
Current: 47.69

During the past 13 years, CK Life Sciences International Holdings's highest Days Payable was 106.67. The lowest was 28.69. And the median was 39.05.

FRA:LSI's Days Payable is ranked worse than
74.44% of 720 companies
in the Biotechnology industry
Industry Median: 147.17 vs FRA:LSI: 47.69

CK Life Sciences International Holdings's Days Payable declined from Dec. 2022 (50.80) to Dec. 2023 (49.55). It may suggest that CK Life Sciences International Holdings accelerated paying its suppliers.


CK Life Sciences International Holdings Days Payable Historical Data

The historical data trend for CK Life Sciences International Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Days Payable Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.08 30.77 27.70 33.66 38.80

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.03 47.05 50.80 56.32 49.55

Competitive Comparison of CK Life Sciences International Holdings's Days Payable

For the Biotechnology subindustry, CK Life Sciences International Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Days Payable falls into.



CK Life Sciences International Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

CK Life Sciences International Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (49.96 + 42.05) / 2 ) / 432.742*365
=46.005 / 432.742*365
=38.80

CK Life Sciences International Holdings's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (79.469 + 42.05) / 2 ) / 223.781*365 / 2
=60.7595 / 223.781*365 / 2
=49.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CK Life Sciences International Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (FRA:LSI) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (FRA:LSI) Headlines